Baxa Sponsors Exhibitor’s Theatre on Avoiding Costly Mistakes in Complying with the Requirements of USP 797
Baxa Corporation is sponsoring a presentation to discuss the new sterile compounding requirements under USP Chapter 797. The Exhibitor’s Theatre presentation, “USP 797: A Practical Approach to Compliance,” will detail the most costly areas of compliance and review the necessary financial and operational resources. The program will take place on Tuesday, December 7th at the meeting of the American Society of Health-System Pharmacists (ASHP) to be held at the Orange County Convention Center in Orlando, Florida.
Englewood, CO (PRWEB) December 2, 2004 -- Baxa Corporation is sponsoring a
presentation to discuss the new sterile compounding requirements under USP
Chapter 797. The Exhibitor’s Theatre presentation, “USP 797: A Practical
Approach to Compliance,” will detail the most costly areas of compliance and
review the necessary financial and operational resources. The program will take
place on Tuesday, December 7th at the meeting of the American Society of
Health-System Pharmacists (ASHP) to be held at the Orange County Convention
Center in Orlando, Florida.
The presentation is expected to help pharmacy
directors and operational managers better understand the design requirements for
cleanrooms, isolators and laminar flow workstations and their application in
meeting the environmental controls outlined for sterile compounding under the
new Chapter. The program will include discussion of recommendations for avoiding
errors and unnecessary cost in the development and execution of action plans for
addressing the pharmacy changes to comply with USP 797.
The presenter,
Eric Kastango, MBA, RPh, is a Fellow of the American Society of Health-System
Pharmacists and has served on the ASHP's Council of Education Affairs and as a
pharmacy surveyor for the Accreditation Commission for Health Care, Inc. (ACHC).
Kastango has made more than 50 invited professional presentations on a variety
of pharmacy practice topics, including USP General Chapter 797 compliance,
sterile preparation and pharmacy compounding errors, quality systems and
collaborative pharmacy/nursing practice models.
ASHP is a 30,000-member
national organization representing pharmacists practicing in hospitals,
homecare, HMOs and alternate-site facilities. The Society provides extensive
published and educational resources that help pharmacists improve their
professional standards and make the best use of medicines and technology for
patient safety and improved outcomes. ASHP holds two annual meetings for members
and industry representatives.
The complimentary educational program will
be held Tuesday, December 7th in Exhibitor’s Theatre 01, Room 305A of the Orange
County Convention Center in Orlando, beginning at 12:45 PM. Participants are
eligible for one credit hour of Continuing Education (CEU).
About Baxa
Corporation
As a leading provider of devices and systems for the preparation,
handling, packaging, and administration of liquid medications, Baxa manufactures
and markets a wide range of healthcare products for use in hospitals, critical
care units and alternate-site pharmacies. Headquartered in Englewood, Colorado,
Baxa has subsidiaries and sales offices in Canada, the United Kingdom; Denmark,
and Germany; and distribution partners worldwide. Further information is
available at http://www.baxa.com.
Click the following link to view a
presentation by Jim Jorgenson "Using a Closed System Device to Reduce
Occupational Exposure to Hazardous Drugs." Jorgenson is Director of Pharmacy for
the Huntsman Cancer Institute and Associate Dean for Professional Affairs at the
University of Utah:
http://www.isips.org/presentations/PhaSeal/player.html
Contacts:
Marian
Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157
or 303.617.2157
Email: e-mail protected from spam bots
Maggie
Chamberlin Holben, APR
Absolutely Public Relations: 303.984.9801 or
303.669.3558
Email: e-mail protected from spam bots
# # #
Source : http://www.prweb.com/releases/2004/12/prweb183883.htm